Skip to main content

Table 3 Relationship between clinicopathological characteristics and risk score calculated by using the 9-lncRNAs signature

From: A nomogram based on 9-lncRNAs signature for improving prognostic prediction of clear cell renal cell carcinoma

Factor

Risk scorea

P value

Low

High

Gender

 Male

175 (67.83%)

163 (63.18%)

0.266

 Female

83 (32.17%)

95 (36.82%)

 

Age

 > 60

120 (46.51%)

137 (53.10%)

0.135

 ≤ 60

138 (53.49%)

121 (46.90%)

 

Grade

 G1 + 2

139 (54.51%)

93 (36.76%)

< 0.001

 G3 + 4

116 (45.49%)

160 (63.24%)

 

N stage

 N0

111 (98.23%)

123 (89.78%)

0.008

 N1

2 (1.77%)

14 (10.22%)

 

T stage

 T1 + 2

193 (98.23%)

136 (89.78%)

0.007

 T3 + 4

65 (1.77%)

122 (10.22%)

 

M stage

 M0

233 (90.66%)

193 (77.51%)

< 0.001

 M1

24 (9.34%)

56 (22.49%)

 

TNM stage

 I + II

185 (71.98%)

126 (49.22%)

< 0.001

 III + IV

72 (28.02%)

130 (50.78%)

 

Status

 Live

214 (82.95%)

133 (51.55%)

< 0.001

 Dead

44 (17.05%)

125 (48.45%)

 
  1. aMedian expression of risk score was used as cut-off value to cut the patients into high risk group and low risk group